Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.19M Sell
349,100
-69,200
-17% -$745K ﹤0.01% 4540
2026
Q1
$3.54M Sell
418,300
-671,200
-62% -$7.34M ﹤0.01% 4919
2025
Q4
$12.3M Buy
1,089,500
+582,300
+115% +$7.21M ﹤0.01% 2787
2025
Q3
$7.61M Buy
507,200
+256,000
+102% +$3.73M ﹤0.01% 3411
2025
Q2
$3.54M Buy
251,200
+124,200
+98% +$2.21M ﹤0.01% 4646
2025
Q1
$3.05M Sell
127,000
-39,700
-24% -$1.4M ﹤0.01% 4608
2024
Q4
$6.23M Sell
166,700
-31,000
-16% -$1.45M ﹤0.01% 3278
2024
Q3
$9.88M Buy
197,700
+31,500
+19% +$1.23M ﹤0.01% 2629
2024
Q2
$5.77M Sell
166,200
-6,600
-4% -$261K ﹤0.01% 3217
2024
Q1
$9.45M Buy
172,800
+10,100
+6% +$500K ﹤0.01% 2680
2023
Q4
$6.96M Sell
162,700
-59,700
-27% -$1.86M ﹤0.01% 3162
2023
Q3
$5.78M Sell
222,400
-118,500
-35% -$2.46M ﹤0.01% 3297
2023
Q2
$8.15M Buy
340,900
+275,500
+421% +$4.74M ﹤0.01% 2782
2023
Q1
$893K Sell
65,400
-27,600
-30% -$439K ﹤0.01% 7108
2022
Q4
$1.29M Buy
+93,000
New +$1.31M ﹤0.01% 5624

Other funds holding BHVN

Jeff Yass's BHVN Position: Q2 2026 in Review

Jeff Yass reduced its Biohaven (BHVN) stake by 41% in Q2 2026, selling an estimated $1.34M and leaving 181,182 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #5849.

Jeff Yass first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $11M in Q1 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Jeff Yass held 181,182 shares of Biohaven worth $2.7M as of Q2 2026.
  • Jeff Yass sold 124,385 Biohaven shares in Q2 2026, an estimated $1.34M.
  • Biohaven made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5849 holding.
  • Jeff Yass first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Jeff Yass's Biohaven position peaked at $11M in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.